Hammerman A, Rotem R, Meidan N, Porath A
Hospital Management and Medical Dept. F, Soroka University Medical Center, Beer Sheba.
Harefuah. 1999 Jun 1;136(11):862-4.
Several studies have documented the impact of clinical pharmacy services on patient care and drug costs in hospital wards. However most hospitals in Israel do not provide such services and until recently their benefits in local health care have not been demonstrated. We therefore determined whether the activity of a pharmacist in the medical department of a medical center leads to improved quality of drug utilization and reduced costs. During the first 3 months of the clinical pharmacist's work all interventions and consultation were documented. The effect of these interventions on drug costs was calculated by the change in drug acquisition costs during the study period compared with those of preceding months, as well as in the other 5 medical departments of the hospital without clinical pharmacy services. During the study period the pharmacist joined 44 clinical rounds in which he documented 40 consultations in response to physicians' requests for drug information and 42 interventions on his own initiative. The pharmacist's recommendations were accepted in 38 of the 42 cases (90%). In 10 cases the pharmacist's initiative in improving the quality of drug therapy led to an increase in drug acquisition costs. However, the overall drug costs during the study period decreased 12.6%. During the same period drug costs in the other medical departments decreased only 2.2%. The results of this study conform with those of many other studies that show a beneficial impact of the clinical pharmacist on the quality of drug therapy and on drug costs. They indicate that the clinical pharmacist can play a crucial role in the medical department.
多项研究记录了临床药学服务对医院病房患者护理和药品成本的影响。然而,以色列的大多数医院并未提供此类服务,并且直到最近其在当地医疗保健中的益处尚未得到证实。因此,我们确定了医疗中心内科药剂师的活动是否会提高药物使用质量并降低成本。在临床药剂师工作的前3个月,记录了所有干预措施和会诊情况。通过将研究期间药品采购成本的变化与前几个月以及医院其他5个未提供临床药学服务的内科进行比较,计算这些干预措施对药品成本的影响。在研究期间,药剂师参加了44次临床查房,他记录了40次应医生对药物信息请求的会诊以及42次主动干预措施。42例中有38例(90%)接受了药剂师的建议。在10例中,药剂师提高药物治疗质量的主动行为导致药品采购成本增加。然而,研究期间的总体药品成本下降了12.6%。同期,其他内科的药品成本仅下降了2.2%。本研究结果与许多其他研究结果一致,这些研究表明临床药剂师对药物治疗质量和药品成本有有益影响。它们表明临床药剂师在内科中可以发挥关键作用。